Teva Pharmaceuticals, one of the country’s largest generic opioid manufacturers, announced a preliminary agreement with 2,500 local governments, states, and tribes regarding the company’s role in the deadly, ongoing opioid epidemic. The agreement, worth up to $4.25 billion, follows a year of scathing trials and previous settlements in individual cases across the country. Teva, an… Continue reading Teva Reaches Tentative $4.25 Billion Settlement Over Opioids
Looking For Market Distribution? Download the Media Kit
